Z-1978-2025 Class II Ongoing
FDA device recall Z-1978-2025 was initiated by Guangzhou Pluslife Biotech Co., Ltd. on Jan 24, 2025 and is designated Class II. Reason for recall: Devices were distributed in the U.S. market without obtaining the required FDA premarket authorization (e.g., 510(k) clearance or PMA). The recall status is ongoing. Affected quantity: 541 units.
Recall details
- Product Type
- Devices
- Report Date
- Jun 25, 2025
- Initiation Date
- Jan 24, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 541 units
Product description
Reason for recall
Distribution pattern
Worldwide distribution: US (nationwide) and OUS (foreign) to countries of: Hong Kong, Australia, Singapore, Palestine, Russia, Ecuador, Papua New Guinea, Indonesia, South Africa, Zimbabwe, Brazil, Tunisia, Samoa, Algeria, Romania, Czech Republic, Thailand, South Korea, Malaysia, Fiji, Nepal, Peru, Mexico, Bahamas, Chile, India, Germany, France, Portugal, Vietnam, Spain, Poland, Latin American Region, Italy, Cameroon, Slovakia, Greece, Hungary Bahrain, Estonia, and Ukraine.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1978-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026